Merck Other Long Term Assets (Quarterly) Analysis

Merck & Co., Inc. (MRK)

109.50 +0.67 (+0.62%) USD | NYSE | Jan 20, 16:00

109.31 -0.19 (-0.17%) After-Hours: 16:42

View Other Long Term Assets (Quarterly) for MRK.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Assets (Quarterly) Benchmarks

Start Trial

Amgen, Inc.	Upgrade
Gilead Sciences, Inc.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade
Cidara Therapeutics, Inc.	Upgrade
Moderna, Inc.	Upgrade